374Water fails Nasdaq independent director rule; cure period until March 9, 2026

374Water Inc.

Company notified Nasdaq on March 13, 2025 it lacks a majority of independent directors per Listing Rule 5605(b)(1).
Cure period expires at earlier of next annual meeting or March 9, 2026; if meeting before Sept 8, 2025, then by Sept 8, 2025.
Company plans to elect an additional independent director as soon as practicable to regain compliance.
No immediate impact on listing or trading of SCWO common stock on Nasdaq Capital Market.
2025 Annual Meeting scheduled for June 11, 2025; stockholder proposals due by April 12, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.